Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole.
To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
These have been produced through consultation with the BIA membership and the investment community. New content will be added to the resources library on an ongoing basis to ensure the guide remains useful and up-to-date as the UK biotech sector grows and evolves.
BIA webinar - How to communicate your R&D to investors and the public
BIA webinar - A practical guide to MiFID II
Code of Practice for the Pharmaceutical Industry 2016 (ABPI)
Example of a good announcement to the market
How to make health news interesting - withouot overselling the claims (The Conversation)
How can we all best use scientific evidence? (Academy of Medical Sciences)
Make it clear (INVOLVE, National Institute for Health Research)
Press release labelling system for new medical research (Science Media Centre)
The following are advisory firms from the BIA membership that provide services to support bioscience companies in achieving high-quality communications and/or complying with legal requirements. If you are a BIA member and would like to be on this list please contact us.